These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Recovery of susceptibility to penicillin G in clinical isolates of Streptococcus pneumoniae despite increased accumulation of pbp gene alterations. Ohsaki Y, Tachibana M, Awaya T, Kuroki M, Itoh Y. Int J Antimicrob Agents; 2008 Nov; 32(5):427-31. PubMed ID: 18715767 [Abstract] [Full Text] [Related]
29. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. Soriano F, Cafini F, Aguilar L, Tarragó D, Alou L, Giménez MJ, Gracia M, Ponte MC, Leu D, Pana M, Letowska I, Fenoll A. J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472 [Abstract] [Full Text] [Related]
30. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Bley C, van der Linden M, Reinert RR. Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605 [Abstract] [Full Text] [Related]
32. Recombination rates of Streptococcus pneumoniae isolates with both erm(B) and mef(A) genes. Lee JY, Song JH, Ko KS. FEMS Microbiol Lett; 2010 Aug 01; 309(2):163-9. PubMed ID: 20618866 [Abstract] [Full Text] [Related]